Vaping Madness
A three-year-old e-cigarette company from China went public on the New York Stock Exchange last month. It’s already worth $35 billion.
China’s Emerging Vaccination Dilemma
As Covid vaccinations ramp up in the rest of the world, China faces two unpalatable choices.
Hao Wu on Bearing Witness in Wuhan
The documentary filmmaker’s newest film offers a raw depiction of Wuhan hospitals during the early days of the Covid-19 outbreak.
China’s New Drug Procurement Program Shakes Up Big Pharma
The new bidding system for generic drugs upends the business of global drug makers in China. The big winners have been Chinese drug makers.
China’s Best Shots
A look at the five Chinese companies furthest along in the search for a Covid-19 vaccine.
The GSK Files
Ten years ago, a single whistleblower sounded the alarm on rampant corruption at GSK's China office. But while the ensuing scandal led to record fines...
Reading When Everything Has Changed
Book recommendations for our swift-changing times, including the first on-the-ground account of life in Wuhan during the lockdown.
U.S. Invokes National Security To Keep ‘Iron Man’ Outfit At Home
How a small company hoping to step into China’s medical market was blocked by a powerful technology gatekeeper.
American Hospitals Take the China Road
In a Chinese medical market predicted to reach $2.4 trillion, famed U.S. clinics team up with private companies to get in on the action.
China and America Are Failing the Pandemic Test
On transnational issues like Covid-19 and climate change, power should be a positive-sum game.
Is America’s Antibiotic Supply at Risk?
The United States no longer produces crucial drugs like penicillin. Instead, China, a strategic rival, now dominates the world’s supply chain. With a global pandemic...
Winston Lord on U.S.–China Cooperation During Covid-19
A veteran diplomat explains why the problems with China pre-date Trump and how the U.S. can pursue smart competition.